Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced instrumentation, reagents, informatics, software, subscriptions, and sophisticated detection and imaging technologies. These resources are designed to enable scientists to achieve significant breakthroughs in…
| Price | $143.08 |
|---|---|
| Market cap | $15.96B |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
| Exchange | NYSE |
| 52-week range | 81.22-149.52 |
| Dividend (TTM) | $0.28 per share |
| Beta | 1.09 |
Explore RVTY's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.